Mark DeStefano, Director of Global Technology Innovation, highlights the latest innovations in drug delivery solutions, including pre-filled syringes, auto-injectors, inhalers, nasal sprays, and implants.
Tardive dyskinesia (TD) is an involuntary movement disorder caused by antipsychotic medications. Often unnoticed by those affected, Bethany Chalmers' young nephew first pointed out her symptoms.
Teva’s sustainability strategy guides how we care for people, the planet and our business—because they are all connected.